Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cambridge

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Pharmacology|March 1, 1995
Canine renovascular responses to sumatriptan and 5-carboxamidotryptamine: modulation through endothelial 5-HT1-like receptors by endogenous nitric oxideM V Whiting, D Cambridge
Cardiovascular Research|June 1, 1986
Evaluation of the QA interval as an index of cardiac contractility in anaesthetised dogs: responses to changes in cardiac loading and heart rateD Cambridge, M V Whiting
British Journal of Pharmacology|January 1, 1988
Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking propertiesD Cambridge, M V Whiting, G Allan
Cardiovascular Research|September 1, 1992
Digoxin and digoxin derivative induced arrhythmias: in vitro binding and in vivo abolition of arrhythmias by digoxin immune Fab (DIGIBAND)D Cambridge, C R Morgan, G Allen
British Journal of Pharmacology|July 1, 1998
Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouseD D Rees, J E Monkhouse, D Cambridge, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1987
Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptaminesG R Martin, P Leff, D Cambridge, et al.
British Journal of Pharmacology|June 1, 1992
The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogsD Cambridge, M V Whiting, L J Butterfield, et al.
British Journal of Pharmacology|March 1, 1995
Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular systemD Cambridge, M V Whiting, L J Butterfield, et al.
British Journal of Pharmacology|March 1, 1987
BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking propertiesG Allan, D Cambridge, G W Hardy, et al.
British Journal of Pharmacology|February 1, 1988
A comparative study of the cardiovascular and biochemical actions of the imidazo [4,5b] pyridine sulmazole and an imidazo [4,5c] pyridine analogue, BW A746CG Allan, D Cambridge, M J Follenfant, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|March 1, 1995
Canine renovascular responses to sumatriptan and 5-carboxamidotryptamine: modulation through endothelial 5-HT1-like receptors by endogenous nitric oxideM V Whiting, D Cambridge
Cardiovascular Research|June 1, 1986
Evaluation of the QA interval as an index of cardiac contractility in anaesthetised dogs: responses to changes in cardiac loading and heart rateD Cambridge, M V Whiting
British Journal of Pharmacology|January 1, 1988
Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking propertiesD Cambridge, M V Whiting, G Allan
Cardiovascular Research|September 1, 1992
Digoxin and digoxin derivative induced arrhythmias: in vitro binding and in vivo abolition of arrhythmias by digoxin immune Fab (DIGIBAND)D Cambridge, C R Morgan, G Allen
British Journal of Pharmacology|July 1, 1998
Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouseD D Rees, J E Monkhouse, D Cambridge, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1987
Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptaminesG R Martin, P Leff, D Cambridge, et al.
British Journal of Pharmacology|June 1, 1992
The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogsD Cambridge, M V Whiting, L J Butterfield, et al.
British Journal of Pharmacology|March 1, 1995
Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular systemD Cambridge, M V Whiting, L J Butterfield, et al.
British Journal of Pharmacology|March 1, 1987
BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking propertiesG Allan, D Cambridge, G W Hardy, et al.
British Journal of Pharmacology|February 1, 1988
A comparative study of the cardiovascular and biochemical actions of the imidazo [4,5b] pyridine sulmazole and an imidazo [4,5c] pyridine analogue, BW A746CG Allan, D Cambridge, M J Follenfant, et al.
Pageof 3